
Top stories



LegalNigeria to implement new tax laws from January 1 despite calls for delay, Tinubu says
Camillus Eboh 21 hours

EducationChoosing a career? In a fast-changing job market, listen to your inner self – counsellor
Kobus Maree 19 hours


“The vaccine protects against the most virulent strain [of meningitis] in Africa that causes 85 percent of all damages and this vaccine will address much of the difficulty [of treatment],” said Professor Marc Laforce, head of the Meningitis Vaccine Project (MVP).
According to Laforce, clinical trials conducted in Senegal, The Gambia and Mali showed positive results. “The vaccine is very immunogenic”, he said.